These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 15044321)

  • 1. SM22alpha modulates vascular smooth muscle cell phenotype during atherogenesis.
    Feil S; Hofmann F; Feil R
    Circ Res; 2004 Apr; 94(7):863-5. PubMed ID: 15044321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SM22α (Smooth Muscle Protein 22-α) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis.
    Sukhanov S; Higashi Y; Shai SY; Snarski P; Danchuk S; D'Ambra V; Tabony M; Woods TC; Hou X; Li Z; Ozoe A; Chandrasekar B; Takahashi SI; Delafontaine P
    Arterioscler Thromb Vasc Biol; 2018 Oct; 38(10):2306-2317. PubMed ID: 30354209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A critical developmental role for tgfbr2 in myogenic cell lineages is revealed in mice expressing SM22-Cre, not SMMHC-Cre.
    Frutkin AD; Shi H; Otsuka G; Levéen P; Karlsson S; Dichek DA
    J Mol Cell Cardiol; 2006 Oct; 41(4):724-31. PubMed ID: 16887142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A G/C element mediates repression of the SM22alpha promoter within phenotypically modulated smooth muscle cells in experimental atherosclerosis.
    Wamhoff BR; Hoofnagle MH; Burns A; Sinha S; McDonald OG; Owens GK
    Circ Res; 2004 Nov; 95(10):981-8. PubMed ID: 15486317
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of FOXO1/3 promotes vascular calcification.
    Deng L; Huang L; Sun Y; Heath JM; Wu H; Chen Y
    Arterioscler Thromb Vasc Biol; 2015 Jan; 35(1):175-83. PubMed ID: 25378413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous p53 protects vascular smooth muscle cells from apoptosis and reduces atherosclerosis in ApoE knockout mice.
    Mercer J; Figg N; Stoneman V; Braganza D; Bennett MR
    Circ Res; 2005 Apr; 96(6):667-74. PubMed ID: 15746445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis.
    Feil S; Fehrenbacher B; Lukowski R; Essmann F; Schulze-Osthoff K; Schaller M; Feil R
    Circ Res; 2014 Sep; 115(7):662-7. PubMed ID: 25070003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeted overexpression of the human urotensin receptor transgene in smooth muscle cells: effect of UT antagonism in ApoE knockout mice fed with Western diet.
    Papadopoulos P; Bousette N; Al-Ramli W; You Z; Behm DJ; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Atherosclerosis; 2009 Jun; 204(2):395-404. PubMed ID: 19111831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-145 targeted therapy reduces atherosclerosis.
    Lovren F; Pan Y; Quan A; Singh KK; Shukla PC; Gupta N; Steer BM; Ingram AJ; Gupta M; Al-Omran M; Teoh H; Marsden PA; Verma S
    Circulation; 2012 Sep; 126(11 Suppl 1):S81-90. PubMed ID: 22965997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-efficiency somatic mutagenesis in smooth muscle cells and cardiac myocytes in SM22alpha-Cre transgenic mice.
    Lepore JJ; Cheng L; Min Lu M; Mericko PA; Morrisey EE; Parmacek MS
    Genesis; 2005 Apr; 41(4):179-84. PubMed ID: 15789423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attenuation of neointimal vascular smooth muscle cellularity in atheroma by plasminogen activator inhibitor type 1 (PAI-1).
    Schneider DJ; Hayes M; Wadsworth M; Taatjes H; Rincón M; Taatjes DJ; Sobel BE
    J Histochem Cytochem; 2004 Aug; 52(8):1091-9. PubMed ID: 15258185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C/EBP-Homologous Protein (CHOP) in Vascular Smooth Muscle Cells Regulates Their Proliferation in Aortic Explants and Atherosclerotic Lesions.
    Zhou AX; Wang X; Lin CS; Han J; Yong J; Nadolski MJ; Borén J; Kaufman RJ; Tabas I
    Circ Res; 2015 May; 116(11):1736-43. PubMed ID: 25872946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptome profiling reveals that the SM22α-regulated molecular pathways contribute to vascular pathology.
    Chen R; Zhang F; Song L; Shu Y; Lin Y; Dong L; Nie X; Zhang D; Chen P; Han M
    J Mol Cell Cardiol; 2014 Jul; 72():263-72. PubMed ID: 24735829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of SM22alpha-deficient mice reveals unanticipated insights into smooth muscle cell differentiation and function.
    Zhang JC; Kim S; Helmke BP; Yu WW; Du KL; Lu MM; Strobeck M; Yu Q; Parmacek MS
    Mol Cell Biol; 2001 Feb; 21(4):1336-44. PubMed ID: 11158319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Kit suppresses atherosclerosis in hyperlipidemic mice.
    Song L; Zigmond ZM; Martinez L; Lassance-Soares RM; Macias AE; Velazquez OC; Liu ZJ; Salama A; Webster KA; Vazquez-Padron RI
    Am J Physiol Heart Circ Physiol; 2019 Oct; 317(4):H867-H876. PubMed ID: 31441677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An overlapping CArG/octamer element is required for regulation of desmin gene transcription in arterial smooth muscle cells.
    Mericskay M; Parlakian A; Porteu A; Dandré F; Bonnet J; Paulin D; Li Z
    Dev Biol; 2000 Oct; 226(2):192-208. PubMed ID: 11023680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of interleukin-1 receptor antagonist modulates plaque composition in apolipoprotein E-deficient mice.
    Isoda K; Sawada S; Ishigami N; Matsuki T; Miyazaki K; Kusuhara M; Iwakura Y; Ohsuzu F
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1068-73. PubMed ID: 15059807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Osteopontin deficiency dampens the pro-atherogenic effect of uraemia.
    Pedersen TX; Madsen M; Junker N; Christoffersen C; Vikeså J; Bro S; Hultgårdh-Nilsson A; Nielsen LB
    Cardiovasc Res; 2013 Jun; 98(3):352-9. PubMed ID: 23455547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular regulation of vascular smooth muscle cell differentiation in development and disease.
    Owens GK; Kumar MS; Wamhoff BR
    Physiol Rev; 2004 Jul; 84(3):767-801. PubMed ID: 15269336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic Evidence Supports a Major Role for Akt1 in VSMCs During Atherogenesis.
    Rotllan N; Wanschel AC; Fernández-Hernando A; Salerno AG; Offermanns S; Sessa WC; Fernández-Hernando C
    Circ Res; 2015 May; 116(11):1744-52. PubMed ID: 25868464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.